Tuberculosis, also known as TB, is a contagious disease that has been affecting humans for centuries. Despite advances in medicine, it continues to be a major global health issue and ranks alongside HIV/AIDS as the leading infectious killer worldwide. As medical professionals, it's important to understand the symptoms of tuberculosis and how to diagnose and treat this disease effectively. In this blog post, we'll dive into everything you need to know about tuberculosis - from its symptoms and diagnosis to available treatment options - so you can better serve your patients and help combat this deadly illness.
Tuberculosis can affect any part of the body, but it usually attacks the lungs. The symptoms of tuberculosis vary depending on which part of your body is affected by the bacteria.
The most common symptom of tuberculosis is a persistent cough that lasts three weeks or longer. Other symptoms include chest pain, coughing up blood or phlegm, fatigue, fever and night sweats.
When TB affects other parts of the body besides the lungs - such as bones, joints or kidneys - patients may experience different symptoms based on where it has spread to. For example, abdominal tuberculosis can cause weight loss and digestive issues like diarrhea and nausea.
One thing to keep in mind is that not everyone infected with TB will develop active disease. In some cases, people with latent TB may have no symptoms at all but are still at risk for developing active TB if left untreated.
Diagnosing tuberculosis is a critical process that involves several steps. The first step in diagnosing TB is a physical exam, which includes checking for symptoms such as coughing, chest pain, fever and weight loss. If a patient shows signs of TB during the physical exam, further testing will be carried out.
One common test used to diagnose TB is the Mantoux test or tuberculin skin test. This test involves injecting a small amount of purified protein derivative (PPD) under the skin on the forearm. A positive reaction indicates exposure to Mycobacterium tuberculosis bacteria.
Another diagnostic method used for TB is chest X-rays or CT scans of the lungs. These images are taken to confirm whether there are any changes in lung tissues caused by TB infection.
A sputum culture may also be conducted to diagnose active pulmonary tuberculosis. Sputum samples collected from an infected person can be cultured to detect mycobacteria and determine if they cause disease.
Abdominal tuberculosis is a type of extrapulmonary tuberculosis that affects the gastrointestinal tract, peritoneum, and lymph nodes in the abdominal cavity. It is caused by Mycobacterium tuberculosis bacteria that spread to the abdomen through blood or lymphatic system.
The symptoms of abdominal TB include abdominal pain, bloating, weight loss, diarrhea or constipation, nausea and vomiting. However, these symptoms are often nonspecific and can be mistaken for other diseases such as inflammatory bowel disease or ovarian cancer.
If left untreated, abdominal TB can lead to severe complications like perforation of intestines or obstruction in the bowel. In some cases, it can even be fatal if there is massive bleeding from ulcers formed du to intestinal TB.
Treatment options for tuberculosis depend on several factors, including the age and overall health of the patient, as well as the severity and location of the infection. In general, treatment for TB involves a combination of antibiotics taken over a period of several months.
The first line drugs used to treat TB include isoniazid, rifampin, ethambutol, and pyrazinamide. Patients may need to take these medications for six to nine months or longer in some cases. It is important that patients complete their full course of treatment even if they start feeling better earlier on in the process.
For patients with drug-resistant strains of TB, more aggressive treatments may be necessary. This can involve taking multiple antibiotics at higher doses over an extended period or receiving intravenous medication directly into a vein.
Tuberculosis is a serious infectious disease that can have severe consequences if left untreated. It's important for medical professionals to understand the symptoms and diagnosis process, as well as the available treatment options.
Symptoms of tuberculosis may include coughing up blood, chest pain, fever, and weight loss. However, there are also other less common symptoms which should not be overlooked.
Diagnosing tuberculosis requires a combination of clinical evaluation and laboratory testing. Chest x-rays, sputum cultures, molecular tests or biopsies can help confirm the presence of TB bacteria in the body.
Abdominal tuberculosis is one manifestation of this disease with high morbidity rates due to late recognition and delayed diagnosis. This highlights the importance of considering abdominal TB when faced with patients presenting with gastrointestinal complaints especially in high burden countries where it’s endemic.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation